Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 2,000 shares at $81.38 ($163K) on 2018-05-08, disclosed to the SEC on 2018-05-10.
Open-market sale of $163k AGIO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AGIO | SELL | 2021-06-11 | $3.4M | — | Filing → |
| AGIO | SELL | 2021-06-09 | $1.3M | — | Filing → |
| AGIO | SELL | 2021-04-21 | $1.9M | — | Filing → |